- Home
- GLPG vs HCI Comparison
GLPG vs HCI Comparison
Compare GLPG & HCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLPG
- HCI
- Stock Information
- Founded
- GLPG 1999
- HCI 2006
- Country
- GLPG Belgium
- HCI United States
- Employees
- GLPG N/A
- HCI N/A
- Industry
- GLPG Biotechnology: Pharmaceutical Preparations
- HCI Property-Casualty Insurers
- Sector
- GLPG Health Care
- HCI Finance
- Exchange
- GLPG Nasdaq
- HCI Nasdaq
- Market Cap
- GLPG 1.8B
- HCI 1.8B
- IPO Year
- GLPG 2005
- HCI N/A
- Fundamental
- Price
- GLPG $27.87
- HCI $151.98
- Analyst Decision
- GLPG Sell
- HCI Strong Buy
- Analyst Count
- GLPG 4
- HCI 4
- Target Price
- GLPG $25.33
- HCI $181.25
- AVG Volume (30 Days)
- GLPG 259.2K
- HCI 168.7K
- Earning Date
- GLPG 07-23-2025
- HCI 08-07-2025
- Dividend Yield
- GLPG N/A
- HCI 1.04%
- EPS Growth
- GLPG N/A
- HCI 4.05
- EPS
- GLPG N/A
- HCI 10.46
- Revenue
- GLPG $311,493,731.00
- HCI $759,870,000.00
- Revenue This Year
- GLPG $0.78
- HCI $19.25
- Revenue Next Year
- GLPG N/A
- HCI $4.08
- P/E Ratio
- GLPG N/A
- HCI $14.22
- Revenue Growth
- GLPG 18.32
- HCI 20.95
- 52 Week Low
- GLPG $22.36
- HCI $83.65
- 52 Week High
- GLPG $31.23
- HCI $176.40
- Technical
- Relative Strength Index (RSI)
- GLPG 51.86
- HCI 41.67
- Support Level
- GLPG $26.62
- HCI $145.30
- Resistance Level
- GLPG $29.28
- HCI $150.86
- Average True Range (ATR)
- GLPG 0.58
- HCI 4.84
- MACD
- GLPG -0.16
- HCI -1.44
- Stochastic Oscillator
- GLPG 54.51
- HCI 20.75
About GLPG Galapagos NV
Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.
About HCI HCI Group Inc.
HCI Group Inc is engaged in the property and casualty insurance business through two Florida domiciled insurance companies, Homeowners Choice Property & Casualty Insurance Company (HCPCI) and TypTap Insurance Company (TypTap). Both HCPCI and TypTap are authorized to underwrite various homeowners' property and casualty insurance products and allied lines business in the state of Florida and other states. The operating segments of the group are insurance operations, TypTap Group, reciprocal exchange operations, real estate operations, and corporate and other. It derives key revenue from the HCPCI Insurance operation segment.